Literature DB >> 26961008

The EQ-5D-5L valuation study in Korea.

Seon-Ha Kim1, Jeonghoon Ahn2, Minsu Ock3, Sangjin Shin2, Jooyeon Park2, Nan Luo4, Min-Woo Jo5,6.   

Abstract

PURPOSE: This study aimed to estimate Korean preference weights for EQ-5D-5L based on values elicited from Korean population by applying the EuroQol Valuation Technology (EQ-VT) program and the standard protocol by the EuroQol Group.
METHODS: The multistage quota sampling method was used to recruit 1085 subjects from the general population in Korea. Each respondent valuated 10 health states using the composite time trade-off (cTTO) and 7 health states using discrete choice experiment. The EQ-VT program was developed by the EuroQol Group and translated into Korean with the Korean research team. Computer-assisted, face-to-face interviews were conducted. A range of predictive models were explored using cTTO. The most appropriate model was determined after assessing goodness of fit, logical consistency, and parsimony.
RESULTS: Of 3206 contacted, 1085 subjects completed interviews (33.8 %) and 1080 were used for modeling. A model with dummy variables for each level of severity and dimension and a term that picked up whether any dimension in the state was at level 4 or 5 was selected as the best predictive model. All coefficients of the final model were statistically significant and logically consistent. In addition, it was parsimonious. This model had mean absolute error of 0.027, and the absolute error for all 86 health states was below 0.1.
CONCLUSIONS: The final model built in this study appears to predict the utilities of the states which were valuated directly. This model could be used to interpolate quality weights for all EQ-5D-5L health states.

Keywords:  Composite time trade-off; Discrete choice experiment; EQ-5D-5L; Quality of life; Social values; Utility

Mesh:

Year:  2016        PMID: 26961008     DOI: 10.1007/s11136-015-1205-2

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  21 in total

1.  Inconsistent responses in three preference-elicitation methods for health states.

Authors:  X Badia; M Roset; M Herdman
Journal:  Soc Sci Med       Date:  1999-10       Impact factor: 4.634

2.  The estimation of a preference-based measure of health from the SF-36.

Authors:  John Brazier; Jennifer Roberts; Mark Deverill
Journal:  J Health Econ       Date:  2002-03       Impact factor: 3.883

3.  Estimating an EQ-5D population value set: the case of Japan.

Authors:  Aki Tsuchiya; Shunya Ikeda; Naoki Ikegami; Shuzo Nishimura; Ikuro Sakai; Takashi Fukuda; Chisato Hamashima; Akinori Hisashige; Makoto Tamura
Journal:  Health Econ       Date:  2002-06       Impact factor: 3.046

4.  Valuing health states: a comparison of methods.

Authors:  P Dolan; C Gudex; P Kind; A Williams
Journal:  J Health Econ       Date:  1996-04       Impact factor: 3.883

5.  US valuation of the EQ-5D health states: development and testing of the D1 valuation model.

Authors:  James W Shaw; Jeffrey A Johnson; Stephen Joel Coons
Journal:  Med Care       Date:  2005-03       Impact factor: 2.983

6.  Psychometric comparison of the standard EQ-5D to a 5 level version in cancer patients.

Authors:  A Simon Pickard; Maria C De Leon; Thomas Kohlmann; David Cella; Sarah Rosenbloom
Journal:  Med Care       Date:  2007-03       Impact factor: 2.983

Review 7.  International comparisons in valuing EQ-5D health states: a review and analysis.

Authors:  Richard Norman; Paula Cronin; Rosalie Viney; Madeleine King; Deborah Street; Julie Ratcliffe
Journal:  Value Health       Date:  2009-08-20       Impact factor: 5.725

8.  A uniform time trade off method for states better and worse than dead: feasibility study of the 'lead time' approach.

Authors:  Nancy J Devlin; Aki Tsuchiya; Ken Buckingham; Carl Tilling
Journal:  Health Econ       Date:  2011-03       Impact factor: 3.046

9.  A pilot discrete choice experiment to explore preferences for EQ-5D-5L health states.

Authors:  Richard Norman; Paula Cronin; Rosalie Viney
Journal:  Appl Health Econ Health Policy       Date:  2013-06       Impact factor: 2.561

10.  Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L).

Authors:  M Herdman; C Gudex; A Lloyd; Mf Janssen; P Kind; D Parkin; G Bonsel; X Badia
Journal:  Qual Life Res       Date:  2011-04-09       Impact factor: 4.147

View more
  81 in total

1.  EQ-5D-5L Valuation for the Malaysian Population.

Authors:  Asrul Akmal Shafie; Annushiah Vasan Thakumar; Ching Jou Lim; Nan Luo; Kim Rand-Hendriksen; Faridah Aryani Md Yusof
Journal:  Pharmacoeconomics       Date:  2019-05       Impact factor: 4.981

2.  Feasibility, comparability, and reliability of the standard gamble compared with the rating scale and time trade-off techniques in Korean population.

Authors:  Seon-Ha Kim; Sang-Il Lee; Min-Woo Jo
Journal:  Qual Life Res       Date:  2017-08-11       Impact factor: 4.147

3.  Mapping EORTC-QLQ-C30 and QLQ-CR29 onto EQ-5D-5L in Colorectal Cancer Patients.

Authors:  Hosein Ameri; Mahmood Yousefi; Mehdi Yaseri; Azin Nahvijou; Mohammad Arab; Ali Akbari Sari
Journal:  J Gastrointest Cancer       Date:  2020-03

Review 4.  A Review of Utility Measurement Methods Used in Pharmacoeconomic Submissions to HIRA in South Korea: Methodological Consistency and Areas for Improvement.

Authors:  Jihyung Hong; Eun-Young Bae
Journal:  Pharmacoeconomics       Date:  2021-07-28       Impact factor: 4.981

5.  Do country-specific preference weights matter in the choice of mapping algorithms? The case of mapping the Diabetes-39 onto eight country-specific EQ-5D-5L value sets.

Authors:  Admassu N Lamu; Gang Chen; Thor Gamst-Klaussen; Jan Abel Olsen
Journal:  Qual Life Res       Date:  2018-03-22       Impact factor: 4.147

6.  A Systematic Review of the Methodologies and Modelling Approaches Used to Generate International EQ-5D-5L Value Sets.

Authors:  Donna Rowen; Clara Mukuria; Emily McDool
Journal:  Pharmacoeconomics       Date:  2022-07-13       Impact factor: 4.558

7.  The Primary Process and Key Concepts of Economic Evaluation in Healthcare.

Authors:  Younhee Kim; Yunjung Kim; Hyeon-Jeong Lee; Seulki Lee; Sun-Young Park; Sung-Hee Oh; Suhyun Jang; Taejin Lee; Jeonghoon Ahn; Sangjin Shin
Journal:  J Prev Med Public Health       Date:  2022-08-24

8.  The Utility of 5 Hypothetical Health States in Heart Failure Using Time Trade-Off (TTO) and EQ-5D-5L in Korea.

Authors:  Sung-Hyun Hong; Jae-Yeon Lee; Sun-Kyeong Park; Jin Hyun Nam; Hyun Jin Song; Sun-Young Park; Eui-Kyung Lee
Journal:  Clin Drug Investig       Date:  2018-08       Impact factor: 2.859

9.  Personalized Type 2 Diabetes Management Using a Mobile Application Integrated with Electronic Medical Records: An Ongoing Randomized Controlled Trial.

Authors:  Eun-Young Lee; Jae-Seung Yun; Seon-Ah Cha; Sun-Young Lim; Jin-Hee Lee; Yu-Bae Ahn; Kun-Ho Yoon; Seung-Hyun Ko
Journal:  Int J Environ Res Public Health       Date:  2021-05-16       Impact factor: 3.390

10.  Chuna Manual Therapy vs Usual Care for Patients With Nonspecific Chronic Neck Pain: A Randomized Clinical Trial.

Authors:  Jinho Lee; Jae-Heung Cho; Koh-Woon Kim; Jun-Hwan Lee; Me-Riong Kim; Joowon Kim; Min-Young Kim; Hyun-Woo Cho; Yoon Jae Lee; Sook-Hyun Lee; Joon-Shik Shin; Lawrence L Prokop; Byung-Cheul Shin; In-Hyuk Ha
Journal:  JAMA Netw Open       Date:  2021-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.